Group B Strep vaccine for pregnant women on the fast track for FDA approval
The following is an excerpt from The Vaccine Reaction. Pfizer is conducting phase 2 trials for the development of a vaccine that will target pregnant women to prevent newborns from infection with Group B Streptococcal (GBS). The vaccine was granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) in September and the […]
Continue reading Group B Strep vaccine for pregnant women on the fast track for FDA approval on sharylattkisson.com.
